Cargando…
CT‐IGFBP‐4 as a novel prognostic biomarker in acute heart failure
AIMS: Insulin‐like growth factor binding protein‐4 (IGFBP‐4) fragments have been shown to predict the risk of major adverse cardiovascular events, including segment‐elevation myocardial infarction, in patients with acute coronary syndrome. We evaluated the prognostic value of the carboxy‐terminal fr...
Autores principales: | Konev, Alexey A., Kharitonov, Alexey V., Rozov, Fedor N., Altshuler, Evgeny P., Serebryanaya, Daria V., Lassus, Johan, Harjola, Veli‐Pekka, Katrukha, Alexey G., Postnikov, Alexander B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160480/ https://www.ncbi.nlm.nih.gov/pubmed/31967738 http://dx.doi.org/10.1002/ehf2.12590 |
Ejemplares similares
-
PAPP-A-Specific IGFBP-4 Proteolysis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Adasheva, Daria A., et al.
Publicado: (2023) -
Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure
por: Öhman, Jonas, et al.
Publicado: (2017) -
Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Jäntti, Toni, et al.
Publicado: (2021) -
Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock
por: Sabell, Tuija, et al.
Publicado: (2020) -
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
por: Hallinen, Taru, et al.
Publicado: (2023)